Rice bran trypsin inhibitor (RBTI) was digested by pepsin alone or by pepsin and pancreatin with or without bovine serum albumin (BSA) to clarify the changes in trypsin inhibitory activity, apparent antigenicity, and molecular size of RBTI. In vitro pepsin digestion of RBTI in the absence of BSA caused the gradual loss of the trypsin inhibitory activity and antigenicity. This was mostly due to a progressive degradation of the native 14.5-kDa RBTI molecule to small molecular mass products. The presence of BSA in the digestion mixture prevented the RBTI degradation and was accompanied with a considerable protec tion of the activity and antigenicity. Similar results were also given by in vitro pepsin-pancreatin digestion. These findings suggest that RBTI may be present in its active form in the gastrointestinal tract when fed to animals, especially with a dietary protein. Key Words in vitro digestion, trypsin inhibitor, pepsin, pancreatin, anti genicity, rice bran It is well known that the ingestion of plant trypsin inhibitors by rats, mice, chicks and other species stimulates the exocrine pancreas, resulting in increased enzyme production and organ enlargement (1, 2). These effects of the inhibitors may depend mostly on their stability in digestive tracts, since the first step in the stimulation is probably that an ingested inhibitor reaches the small intestine in its active form and combines with trypsin. Therefore, it is extremely important to know the behavior of an inhibitor in the gastrointestinal tract to understand its nutritional significance.
Summary
Rice bran trypsin inhibitor (RBTI) was digested by pepsin alone or by pepsin and pancreatin with or without bovine serum albumin (BSA) to clarify the changes in trypsin inhibitory activity, apparent antigenicity, and molecular size of RBTI. In vitro pepsin digestion of RBTI in the absence of BSA caused the gradual loss of the trypsin inhibitory activity and antigenicity. This was mostly due to a progressive degradation of the native 14.5-kDa RBTI molecule to small molecular mass products. The presence of BSA in the digestion mixture prevented the RBTI degradation and was accompanied with a considerable protec tion of the activity and antigenicity. Similar results were also given by in vitro pepsin-pancreatin digestion. These findings suggest that RBTI may be present in its active form in the gastrointestinal tract when fed to animals, especially with a dietary protein.
Key Words in vitro digestion, trypsin inhibitor, pepsin, pancreatin, anti genicity, rice bran It is well known that the ingestion of plant trypsin inhibitors by rats, mice, chicks and other species stimulates the exocrine pancreas, resulting in increased enzyme production and organ enlargement (1, 2) . These effects of the inhibitors may depend mostly on their stability in digestive tracts, since the first step in the stimulation is probably that an ingested inhibitor reaches the small intestine in its active form and combines with trypsin. Therefore, it is extremely important to know the behavior of an inhibitor in the gastrointestinal tract to understand its nutritional significance.
We have previously reported on the purification, characterization, and amino acid sequence of rice bran trypsin inhibitor (RBTI) (3) (4) (5) (6) . Briefly, this inhibitor is a heat-stable protein with a molecular weight of 14,500 consisting of two tandem, homologous Bowman-Birk type inhibitors and can inhibit trypsins from various species such as bovine, hog, rat, and human. These properties imply that RBTI plays an important role in animal nutrition when ingested. However, the behavior of the RBTI molecule in the digestive tracts is not clear after being fed to animals. Figure 3 shows SDS-PAGE and immunoblot patterns of the pepsin digests. It was clearly seen that pepsin progressively degraded the native 14.5-kDa RBTI molecule to small molecular mass products in the absence of BSA. The degradation products detected by SDS-PAGE with a reducing agent were mainly 7.5-kDa and 8.5-kDa species within 2h of digestion, and those with less molecular mass species over 2h of digestion. It also turned out that intact RBTI completely disappeared over 3h of digestion. Among the degradation products, the 8.5-kDa species was found to be most immunoreactive when judged by immunoblot patterns. On the other hand, pepsin scarcely degraded the RBTI molecule when BSA was added to the reaction mixture. This resistance to digestion by pepsin was still observed even after the original BSA molecule completely disappeared.
The change in the molecular size of RBTI during the pepsin digestion was also examined by HPLC, in which a successive diminution in the original RBTI peak was shown in the absence of BSA and the nearly complete maintenance of the peak in the presence of BSA, as shown in Fig. 4 . These findings are in good agreement with the results obtained from SDS-PAGE.
In vitro pepsin pancreatin digestion of RBTI RBTI was digested by pepsin for 30min under the same conditions as above, and subsequently by pancreatin for 24h at pH 8.0. In the digestion, the pancreatin 
DISCUSSION
Rice bran is a valuable byproduct as a potential source of food protein, because it contains a large amount of proteins with high nutritional quality. However, we have indicated that rice bran also contains a significant amount of a proteinaceous trypsin inhibitor (RBTI) (3) regarded as an antinutritional factor. Therefore, in order to utilize rice bran proteins as a food, it is necessary to clarify the physiolog ical effect of RBTI on animals and man. From this viewpoint, we constructed in vitro digestion systems of RBTI and examined the changes in the inhibitory activity, antigenicity, and molecular size of RBTI during digestion.
In vitro pepsin digestion in the absence of BSA clearly showed that RBTI gradually lost its inhibitory activity during the digestion. This was mainly due to a progressive degradation of native RBTI to small molecular mass products. How ever, the residual inhibitory activity did not necessarily correspond to the amount of intact RBTI molecule remaining. In particular, it should be noted that about 30% of the original activity still remained even after the intact RBTI molecule completely disappeared. The above fact demonstrates that one or more degradation products derived from the RBTI molecule have some trypsin inhibitory activity. These products with the inhibitory activity seem to be the 7.5-kDa and 8.5-kDa species that are probably derivatives of the constituent domains of RBTI, since RBTI consists of two tandem, homologous Bowman-Birk type inhibitors with a molecular weight of about 8,000 (6). The idea is also supported by the result of pepsin-pancreatin digestion without BSA, because the activity loss caused by pancreatin is judged to be attributed to the degradation of the 7.5-kDa product.
The inhibitory activity loss caused by pepsin digestion was strongly prevented by the addition of BSA to the digestion mixture. This was clearly due to the protection effect of BSA to the RBTI degradation, as indicated by SDS-PAGE and HPLC. The effect of BSA is believed to be based upon its susceptibility to pepsin. BSA possibly competes with RBTI for pepsin. It is also probable that peptides derived from the BSA molecule by pepsin digestion compete with RBTI for pepsin, because RBTI fairly maintained its molecular size during pepsin digestion even after the original BSA molecule completely disappeared. In any case, a dietary protein ingested together with RBTI probably works as a protector of RBTI unless the protein is indigestible to pepsin. Therefore, RBTI is thought to be highly active in the stomach after it was ingested as a part of food constituents by animals. In addition, it is likely that RBTI exhibits substantial trypsin inhibitory activity even in the small intestine, since this inhibitor was indicated to be resistant to pancreatin. product is also anticipated to combine with the antiserum to form a larger precipitin circle in SRID than intact RBTI, since it seems that the 8.5-kDa species diffuses more rapidly in an agarose gel than RBTI because of its smaller molecular size.
This may be the reason why the apparent antigenicity of a digest did not necessarily correspond to the inhibitory activity. However, it is suggested that the antigenicity determined by SRID is a more useful indicator than the inhibitory activity for evaluating the unabsorbed amounts of RBTI and its degradation products remain ing in actual digestive tracts.
